2026 NPPES data Addiction Medicine (Psychiatry & Neurology) Physician NPI 1003920760 D.O.
Verify on CMS →

MICHAEL BUXBAUM, D.O.

Addiction Medicine (Psychiatry & Neurology) Physician in HOUSTON, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
13K
Medicare Part D claims · 621 beneficiaries · Addiction Medicine (Psychiatry & Neurology) Physician avg: 1K
Generic prescribing
87%
generic claims · 13% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
22.8134/100
▼ 60 pts below national avg 83.1 · [object Object]
Industry payments
$38.17
2 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: MICHAEL BUXBAUM, D.O. is a Addiction Medicine (Psychiatry & Neurology) Physician ([object Object]) practicing in HOUSTON, Texas with a Medicare Part D prescribing footprint of 13K claims across 621 beneficiaries — 13% brand-name prescribing . Their CMS MIPS Final Score of 22.8134/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $38.17 across 2 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: MICHAEL BUXBAUM, D.O. reported a CMS MIPS final score of 22.8134 out of 100, below the 83.1 national average, and filed 12,986 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

MICHAEL BUXBAUM, D.O. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

MICHAEL BUXBAUM, D.O. at a glance

Below national average

NPI registry status

Active

Issued 08/19/2006

NPI 1003920760

Primary specialty

Addiction Medicine (Psychiatry & Neurology) Physician

Niche

658 US NPIs in this specialty

Medicare Part D claims

12,986 1174% vs specialty avg

2023 prescription claims

Specialty avg: 1,019

MIPS final score

22.8134/100 60.28659999999999% pts

Below average band

vs 83.1 national avg

Specialty distribution in Texas

How Addiction Medicine (Psychiatry & Neurology) Physician compares to other specialties among Texas providers

Texas providers

Addiction Medicine (Psychiatry & Neurology) Physician share within Texas

1. Addiction Medicine (Psychiatry & Neurology) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Addiction Medicine (Psychiatry & Neurology) Physician share within Texas

Medicare quality performance — MIPS

MICHAEL BUXBAUM, D.O.'s 2023 MIPS final score plotted against the Addiction Medicine (Psychiatry & Neurology) Physician national average

Below national average
MIPS Final Score
22.8134/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Addiction Medicine (Psychiatry & Neurology) Physician) — 22.8134/100 vs national avg 83.1

0%100%National avg83%22.8%
MIPS final score (Addiction Medicine (Psychiatry & Neurology) Physician) — 22.8134/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MICHAEL BUXBAUM, D.O. is a Addiction Medicine (Psychiatry & Neurology) Physician provider practicing in HOUSTON, Texas, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: D.O.. NPI: 1003920760. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MICHAEL BUXBAUM, D.O. appears in the CMS NPPES registry as a Addiction Medicine (Psychiatry & Neurology) Physician provider holding D.O. credentials at 3100 WESLAYAN ST STE 350, HOUSTON, TX, 77027, with a listed phone of (713) 533-1700. NPI 1003920760 was issued on 08/19/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BUXBAUM most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 12,986 prescription claims written by this provider, covering 621 Medicare beneficiaries and totaling roughly $995K in drug spend, split 13% brand-name and 87% generic by claim count, with an opioid prescribing rate of 0.5%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 22.8134/100 for the 2023 performance year (Quality 35, Cost 12.7112), compared with the national average of 83.1.

Addiction Medicine (Psychiatry & Neurology) Physician is a narrow specialty nationwide, with 658 enrolled providers across 49 states and an average of 1,019 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

3100 WESLAYAN ST STE 350
HOUSTON, TX 77027

Provider Details

NPI 1003920760
Specialty Addiction Medicine (Psychiatry & Neurology) Physician
Credentials D.O.
Gender Male
NPI Issued 08/19/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

22.8134
Final Score
Avg: 83.1
35
Quality
12.7112
Cost

Reporting: Individual

Hospital and facility affiliations

Facilities where MICHAEL BUXBAUM, D.O. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

MICHAEL E BUXBAUM DO PA
HOUSTON, TX

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MICHAEL BUXBAUM, D.O.. Source: openpaymentsdata.cms.gov.

Total received

$38

Largest payer

Lilly USA, LLC

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Texas TMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to MICHAEL BUXBAUM, D.O.. To verify MICHAEL BUXBAUM, D.O.'s current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

MICHAEL BUXBAUM, D.O. — brand share 13.0%
Specialty average (est.)

13% brand-name claims vs 87% generic, on 12,986 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

12,986
Total Claims
$995K
Total Drug Cost
621
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
21,591
Total Day Supply
597,579
Brand vs Generic
13% brand / 87% generic
Brand Drug Cost
$704K
Generic Drug Cost
$285K
Opioid Claims
68 (0.5% rate)
Antibiotic Claims
331

Patient Demographics

Average Patient Age
75.6 years
Avg HCC Risk Score
2.19
Gender Split
60% female / 40% male
Age Distribution
<65: 55, 65-74: 225, 75-84: 218, 85+: 123

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Atorvastatin Calcium
656
Levothyroxine Sodium
526
Amlodipine Besylate
482
Gabapentin
343
Furosemide
340
Lisinopril
320
Losartan Potassium
308
Eliquis
Apixaban
290
Metoprolol Succinate
245
Tamsulosin Hcl
242

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Addiction Medicine (Psychiatry & Neurology) Physician Overview

How MICHAEL BUXBAUM, D.O. fits within the Addiction Medicine (Psychiatry & Neurology) Physician landscape nationally.

658
Addiction Medicine (Psychiatry & Neurology) Physician Providers in US
49
States with Addiction Medicine (Psychiatry & Neurology) Physician
1,019
Avg Claims per Provider

MICHAEL BUXBAUM, D.O.'s 12,986 claims are above the specialty average of 1,019.

Nearby Addiction Medicine (Psychiatry & Neurology) Physician Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as BUXBAUM.

Compare Addiction Medicine (Psychiatry & Neurology) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MICHAEL BUXBAUM, D.O.'s specialty?
MICHAEL BUXBAUM, D.O. specializes in Addiction Medicine (Psychiatry & Neurology) Physician and practices in HOUSTON, Texas. Credentials: D.O..
How much does MICHAEL BUXBAUM, D.O. prescribe under Medicare Part D?
In 2023, MICHAEL BUXBAUM, D.O. wrote 12,986 Medicare Part D claims totaling $995K in drug costs for 621 beneficiaries.
What is MICHAEL BUXBAUM, D.O.'s Medicare quality score?
MICHAEL BUXBAUM, D.O. has a CMS MIPS Final Score of 22.8134/100 (Quality: 35, Cost: 12.7112). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MICHAEL BUXBAUM, D.O. located?
MICHAEL BUXBAUM, D.O. is located at 3100 WESLAYAN ST STE 350, HOUSTON, TX, 77027. Phone: (713) 533-1700.
What is MICHAEL BUXBAUM, D.O.'s NPI number?
MICHAEL BUXBAUM, D.O.'s National Provider Identifier (NPI) is 1003920760, issued on 08/19/2006.
Does MICHAEL BUXBAUM, D.O. prescribe more brand-name or generic drugs?
MICHAEL BUXBAUM, D.O.'s prescribing is 13% brand-name and 87% generic drugs by claim count, with $704K in brand drug costs.
Does MICHAEL BUXBAUM, D.O. prescribe opioids?
Yes, MICHAEL BUXBAUM, D.O. had 68 opioid claims in 2023 with an opioid prescribing rate of 0.5%.
How many Addiction Medicine (Psychiatry & Neurology) Physician providers are there in the US?
There are 658 Addiction Medicine (Psychiatry & Neurology) Physician providers across 49 states in the US. The average Addiction Medicine (Psychiatry & Neurology) Physician provider writes 1,019 Medicare Part D claims per year.
What drugs does MICHAEL BUXBAUM, D.O. prescribe most often?
Based on 2023 Medicare Part D data, MICHAEL BUXBAUM, D.O.'s most frequently prescribed drugs include Atorvastatin Calcium, Levothyroxine Sodium, Amlodipine Besylate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MICHAEL BUXBAUM, D.O. accept Medicare?
MICHAEL BUXBAUM, D.O. appears in CMS Medicare data with 12,986 Part D claims and 621 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MICHAEL BUXBAUM, D.O.'s credentials?
MICHAEL BUXBAUM, D.O.'s NPI is 1003920760 with credentials D.O.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology